Decoy Therapeutics Inc. (DCOY): Depreciation & Amortization
$7.2K
Year ended 2025-12-31
$24.5K
Trailing 12 months to 2026-06-30
+2.3%
3-year compound annual growth
-16.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.2K | +61.6% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $4.4K | -56.0% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $10.1K | +50.5% | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | $6.7K | -65.2% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $19.2K | +6.2% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $18.1K | -85.8% | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | $127.4K | +651.7% | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | $16.9K | n/a | 2020-03-23, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $7.2K | +61.6% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $17.3K | 0.0% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $55.0K | -86.7% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $61.0K | +408.3% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $290.1K | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $52.7K | +11.1% |
| Imunon, Inc. (IMNN) | 2024-12-31 | $240.0K | -3.2% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $72.0K | -42.9% |
Compare DCOY, LTRN, NCEL, TRAW side by side · Screen every company in Pharmaceutical Preparations ↗